Mycobacterial infectious disease
MONDO:0020590Infection due to organisms from the genus Mycobacteria.
Also known as: mycobacterial infection, mycobacteriosis, mycobacterium infection
360 clinical trials for this condition and its sub-types, 23 tagged with Mycobacterial infectious disease itself.
Follow this condition to get notified about new trialsWhere it sits in the disease tree
Browse by category →Sub-types of Mycobacterial infectious disease
-
Tuberculosis 216 trials · 298 incl. sub-types
12 sub-types
- Pulmonary tuberculosis 107 trials · 110 incl. sub-types Sub-types →
- Latent tuberculosis infection 72 trials
- Drug-resistant tuberculosis 9 trials · 40 incl. sub-types Sub-types →
- Extrapulmonary tuberculosis 6 trials · 28 incl. sub-types Sub-types →
- Active tuberculosis 23 trials
- Tuberculous encephalopathy 1 trial
- Endocrine tuberculosis 0 trials Sub-types →
- Multifocal tuberculosis 0 trials
- Primary bone and joint tuberculosis 0 trials
- Primary tuberculosis of the digestive system 0 trials
- Primary tuberculous lymphadenitis 0 trials
- Tuberculoma 0 trials
-
Mycobacterium avium complex disease 22 trials
-
Leprosy 11 trials · 12 incl. sub-types
6 sub-types
- Lepromatous leprosy 3 trials
- Multibacillary leprosy 3 trials
- Borderline leprosy 0 trials
- Indeterminate leprosy 0 trials
- Paucibacillary leprosy 0 trials
- Tuberculoid leprosy 0 trials
-
Buruli ulcer disease 3 trials
-
Mycobacterium xenopi infection 2 trials
-
Aquarium granuloma 0 trials
Most studied deeper sub-types
-
Supercharged immune cells take on Drug-Resistant infections
Disease control Stopped earlyThis trial investigates whether specially grown immune cells, called pathogen-specific cytotoxic T lymphocytes (CTLs), can safely and effectively treat stubborn infections like EBV, CMV, and adenovirus in people with weakened immune systems, such as stem cell or organ transplant …
Phase 1/2 • Sponsor: Shenzhen Geno-Immune Medical Institute • Aim: Disease control
Last updated Aug 26, 2026 00:00 UTC
-
Could a 3-Month TB cocktail replace the standard 6-Month regimen?
Disease control Stopped earlyThis clinical trial investigates whether a 3-month combination of clofazimine and rifapentine can effectively treat drug-susceptible tuberculosis (TB) compared to the standard 6-month regimen. The study includes adults with pulmonary TB, some of whom also have HIV. Researchers ar…
Phase 2 • Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) • Aim: Disease control
Last updated Jul 10, 2026 00:00 UTC
-
New hope for stubborn lung infection? trial of epetraborole begins, then stops
Disease control Stopped earlyThis study tested an oral drug called epetraborole for people with a tough-to-treat lung infection called MAC lung disease. The trial aimed to see if adding epetraborole to standard treatment could improve symptoms and clear the infection. However, the study was terminated early,…
Phase 2/3 • Sponsor: AN2 Therapeutics, Inc • Aim: Disease control
Last updated Jun 27, 2026 13:07 UTC
-
Could aspirin or ibuprofen help beat TB faster?
Disease control Stopped earlyThis study tested whether adding aspirin or ibuprofen to standard tuberculosis (TB) treatment helps patients recover more quickly. It included 426 adults with drug-sensitive or drug-resistant TB. The trial was terminated early, so the results are not conclusive.
Phase 2 • Sponsor: Fundació Institut Germans Trias i Pujol • Aim: Disease control
Last updated Jun 27, 2026 13:00 UTC
-
New TB drug cocktails aim to cut treatment time in half
Disease control Stopped earlyThis clinical trial tested whether combining several drugs—bedaquiline, OPC-167832, sutezolid, and either pretomanid or delamanid—could treat pulmonary tuberculosis in just 2 to 4 months instead of the standard 6 months. The study enrolled 93 adults with drug-sensitive or drug-re…
Phase 2 • Sponsor: Gates Medical Research Institute • Aim: Disease control
Last updated Jun 27, 2026 12:35 UTC
-
New inhaled drug aimed at stubborn lung infection shows promise, but trial halted early
Disease control Stopped earlyThis phase 3 study tested an inhaled form of the antibiotic clofazimine added to standard therapy for people with MAC lung disease that did not respond to previous treatment. The goal was to see if the drug could clear the infection from sputum cultures and improve quality of lif…
Phase 3 • Sponsor: Mannkind Corporation • Aim: Disease control
Last updated Jun 27, 2026 07:57 UTC
-
TB prevention study halted early – only 16 volunteers enrolled
Prevention Stopped earlyThis study aimed to see if a single dose of the BCG vaccine could prevent tuberculosis infection in healthy adults traveling to countries with high TB rates. Participants were randomly assigned to receive either BCG or a placebo. The study was terminated early and enrolled only 1…
Phase 3 • Sponsor: Henry M. Jackson Foundation for the Advancement of Military Medicine • Aim: Prevention
Last updated Jun 27, 2026 08:13 UTC
-
Pregnancy drug study aims to protect moms and babies from HIV and TB
Knowledge-focused Stopped earlyThis study looked at how HIV and tuberculosis (TB) medications are processed in the bodies of pregnant women and new mothers. Researchers measured drug levels in the blood of 205 women during pregnancy and after delivery to see if standard doses are effective. The goal was to gat…
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) • Aim: Knowledge-focused
Last updated Aug 28, 2026 00:00 UTC